Sturm’s conoid
Sturm's conoid optics astigmatism focal lines
https://www.aao.org/Assets/86407d70-b8b4-4a03-92ae-057473a79…

| Structure | Description |
|---|---|
| First focal line | A line focus formed by the more powerful (more curved) meridian - this line lies perpendicular to that meridian |
| Circle of Least Confusion (CoLC) | A circular cross-section midway between the two focal lines; the point where the beam is most "point-like" |
| Second focal line | A line focus formed by the less powerful (flatter) meridian - perpendicular to the first focal line |
| Focal interval | The axial distance between the two focal lines; its length is proportional to the degree of astigmatism |
| Type | Focal lines position |
|---|---|
| Simple myopic astigmatism | One focal line on retina, the other in front |
| Simple hyperopic astigmatism | One focal line on retina, the other behind |
| Compound myopic astigmatism | Both focal lines in front of the retina |
| Compound hyperopic astigmatism | Both focal lines behind the retina |
| Mixed astigmatism | One focal line in front, one behind the retina (retina passes through the conoid) |
I have to write in exam internal ophthalmology final year MBBS. SHORT NOTE 5 marker type
First focal Circle of Second focal
line Least Confusion line
| | |
●━━━━━━━━━━━━━●━━━━━━━━━━━━━●
(more powerful (less powerful
meridian) meridian)
←——— Focal Interval ———→
| Component | Description |
|---|---|
| First focal line | Line focus of the stronger meridian |
| Second focal line | Line focus of the weaker meridian; perpendicular to first |
| Focal interval | Axial distance between the two focal lines; proportional to degree of astigmatism |
| Circle of Least Confusion (CoLC) | Circular cross-section at the midpoint of the focal interval; smallest and most point-like section of the conoid |
SE = Sphere + (Cylinder ÷ 2)
Acute Pancreatitis final year MBBS SURGERY
| Category | Examples |
|---|---|
| I - Idiopathic | 10-20% of cases |
| G - Gallstones | Most common cause (accounts for ~40-50%) |
| E - Ethanol (alcohol) | Second most common |
| T - Trauma | Blunt abdominal trauma, post-ERCP |
| S - Steroids | Corticosteroids |
| M - Mumps / infections | Coxsackievirus, ascariasis |
| A - Autoimmune | Autoimmune pancreatitis |
| S - Scorpion sting / hypertriglyceridemia (>1000 mg/dL) | |
| H - Hypercalcemia / Hyperlipidemia | Hyperparathyroidism |
| E - ERCP (post-procedural) | Iatrogenic |
| D - Drugs | Azathioprine, thiazides, estrogens, anticonvulsants |
Gallstones + alcohol = nearly 80% of all cases.
| Test | Finding / Significance |
|---|---|
| Serum amylase | >3x normal is diagnostic; peaks within hours, normalizes by 48-72h; less specific |
| Serum lipase | More specific than amylase; remains elevated longer (8-14 days); preferred |
| WBC | Leukocytosis |
| Blood glucose | Hyperglycemia (islet cell damage) |
| Serum calcium | Hypocalcemia (saponification - fat necrosis binds calcium) |
| Serum LDH, AST | Elevated |
| Hematocrit | Raised (hemoconcentration from third-spacing) |
| S. Bilirubin / LFTs | Elevated in biliary pancreatitis |
| ABG | PaO2 may fall (acute lung injury / ARDS) |
| CRP | >150 mg/L at 48h defines severe disease |
| Modality | Findings |
|---|---|
| X-ray abdomen | "Sentinel loop" (gas-distended proximal jejunum), "colon cut-off" sign |
| CXR | Left-sided pleural effusion (indicates severity) |
| USG abdomen | First-line: detects gallstones, CBD dilatation, pancreatic edema, peripancreatic fluid; sensitivity limited by bowel gas |
| CECT abdomen | Gold standard for severity assessment - shows necrosis, fluid collections, abscess; done at 48-72h |
| MRCP | For biliary anatomy, suspected pancreas divisum, recurrent pancreatitis |
| Grade | Criteria |
|---|---|
| Mild | No organ failure, no local/systemic complications |
| Moderately severe | Transient organ failure (<48h) and/or local/systemic complications |
| Severe | Persistent organ failure (>48h) |
Score <3 = mild (mortality <1%) | Score ≥3 = severe | Score >6 = mortality ~50%
| Point | Detail |
|---|---|
| Most common cause | Gallstones (India: alcohol is close second) |
| Cardinal symptom | Epigastric pain radiating to back |
| Drug of choice for pain | Pethidine (morphine contraindicated) |
| Best diagnostic test | Serum lipase (more specific + prolonged elevation) |
| Gold standard imaging | CECT abdomen |
| Severity scoring | Ranson's criteria (≥3 = severe) |
| Grey Turner's sign | Flank ecchymosis = hemorrhagic pancreatitis |
| Cullen's sign | Periumbilical ecchymosis = hemorrhagic pancreatitis |
| Preferred nutrition in severe AP | Enteral (nasojejunal) feeding |
| Surgery timing for gallstones | Cholecystectomy in same admission after recovery |
Pseudocyst
Key distinguishing feature: No epithelial lining (true cysts have epithelial lining)
| Test | Finding |
|---|---|
| Serum amylase / lipase | Persistently elevated after pancreatitis |
| WBC | Elevated if infected |
| LFTs / bilirubin | Elevated if biliary compression |
| Modality | Findings |
|---|---|
| USG abdomen | First-line; shows anechoic (fluid-filled) rounded mass; detects size, location |
| CECT abdomen | Gold standard - shows cyst wall, contents (fluid vs solid material), relation to stomach/duodenum, extent of necrosis; helps plan drainage |
| MRI / MRCP | Best for characterizing contents (fluid vs solid/debris); shows ductal communication and anatomy non-invasively |
| EUS (Endoscopic USG) | Used when cystic neoplasm cannot be excluded; allows FNA of cyst fluid |
| Barium meal (old) | Widening of the C-loop of duodenum; stomach displaced anteriorly |
| Parameter | Pseudocyst | Mucinous Neoplasm |
|---|---|---|
| Amylase | Very HIGH | Variable |
| CEA | LOW (<5 ng/mL) | HIGH (>400 ng/mL) |
| Cytology | Inflammatory cells, no mucin | Mucinous/malignant cells |
| Complication | Notes |
|---|---|
| Infection / Abscess | Fever, pain, leukocytosis; requires urgent drainage |
| Haemorrhage | Erosion into a vessel (splenic artery most common) → pseudoaneurysm → rupture into cyst → "haemosuccus pancreaticus" (blood in pancreatic duct/GI tract); mortality >40% |
| Rupture | Into peritoneum → peritonitis; into gut → GI bleeding / internal fistula; into pleural space → pancreatic pleural effusion |
| Obstructive jaundice | Compression of CBD |
| Bowel obstruction | Gastric outlet / duodenal compression |
| Pancreatic ascites | Rupture into peritoneum with chronic leak |
| Splenic vein thrombosis | → Portal hypertension, gastric varices |
Asymptomatic pseudocysts - observe conservatively; most will resolve
Internal drainage is always preferred over external drainage
| Method | Route | Best For | Success | Drawback |
|---|---|---|---|---|
| Endoscopic (EUS) | Transgastric/transduodenal | Cysts near stomach/duodenum | 80-90% | Operator skill needed |
| Surgical (cystogastrostomy) | Open/laparoscopic | All locations; failed endoscopy | >95% | Invasive |
| Percutaneous | Skin → cyst | Infected cyst, septic patient | Low | Fistula risk |
| Point | Fact |
|---|---|
| Definition | Fluid collection with NO epithelial lining, wall of fibrous/granulation tissue |
| Minimum time to form | 4 weeks after acute pancreatitis |
| Most common cause | Acute pancreatitis (gallstones/alcohol) |
| Most common site | Lesser sac (behind stomach) |
| % that communicate with PD | 50-70% |
| % resolve spontaneously | Up to 70% |
| Distinguishing from cyst neoplasm | Low CEA + high amylase in fluid |
| Most dangerous complication | Haemorrhage (>50% of pseudocyst mortality) |
| First-line drainage | Endoscopic (EUS-guided) |
| Surgical procedure of choice | Cystogastrostomy |
| Percutaneous drainage - why avoided? | Risk of pancreaticocutaneous fistula |
I want to explain Cystogastrostomy in short if possible with a small diagram
Simple clean medical illustration diagram of surgical cystogastrostomy for pancreatic pseudocyst. Cross-sectional schematic view showing: the stomach in the upper portion with its anterior wall and posterior wall clearly labelled, a large oval pseudocyst sitting behind the stomach in the lesser sac labelled "Pancreatic Pseudocyst", the pancreas labelled below/behind the pseudocyst. A clear opening shown between the posterior wall of the stomach and the anterior wall of the pseudocyst, labelled "Cystogastrostomy anastomosis (6-8 cm opening)". Arrows showing direction of fluid drainage from the pseudocyst into the stomach lumen. The gastric lumen labelled. Step annotations: Step 1 - anterior gastrotomy, Step 2 - posterior gastric wall incised into pseudocyst, Step 3 - anastomosis sutured. Clean black and white line drawing style with clear labels, suitable for a medical exam note or textbook.

Works because: ~35% of pseudocysts lie in the lesser sac, directly fused against the posterior gastric wall - making the stomach the nearest and most natural drainage route.
STEP 1 — ANTERIOR GASTROTOMY
↓
STEP 2 — IDENTIFY BULGE in posterior gastric wall
(confirm by needle aspiration → amylase-rich fluid)
↓
STEP 3 — INCISE POSTERIOR GASTRIC WALL + PSEUDOCYST WALL
(electrocautery, 6-8 cm opening)
↓
STEP 4 — EVACUATE cyst contents + debris + send for cytology/biopsy
↓
STEP 5 — SUTURE anastomosis
(locking running stitch, 2-0 absorbable monofilament,
full thickness of posterior gastric wall + cyst wall)
↓
STEP 6 — CLOSE anterior gastrotomy in two layers
| Point | Detail |
|---|---|
| Incision | Midline epigastric (~12 cm) |
| Anterior gastrotomy | 6-8 cm transverse cut between stay sutures |
| Confirming pseudocyst | Visible bulge in posterior wall + needle aspiration of amylase-rich fluid |
| Size of anastomosis | 6-8 cm (wide enough to prevent re-accumulation) |
| Suture | Locking running stitch - prevents bleeding from gastric submucosal vascular plexus |
| Biopsy | Always take a full-thickness biopsy of the cyst wall to exclude cystic neoplasm |
| Close anterior gastrotomy | Two layers - inner absorbable running + outer silk |
EUS probe identifies pseudocyst through posterior gastric wall
↓
EUS-guided needle puncture through posterior gastric wall into cyst
↓
Guidewire coiled inside cyst cavity
↓
Tract dilated (balloon dilatation)
↓
Double-pigtail stent placed
(one end in cyst, other end in stomach lumen)
↓
Cyst drains continuously into stomach → collapses over weeks
| Feature | Open Surgical | Endoscopic (EUS) |
|---|---|---|
| Recurrence rate | <5% (gold standard) | ~10-15% |
| Hospital stay | Longer | Shorter |
| Invasiveness | Open laparotomy | Minimally invasive |
| Cost | Higher | Lower |
| Availability | Universal | Needs expert endoscopist |
| Preferred when | Endoscopy fails; large debris; neoplasm excluded | First-line in most centres |
Cystogastrostomy = surgical (or endoscopic) creation of a permanent opening between the posterior wall of the stomach and the anterior wall of an adherent pseudocyst, allowing the cyst to drain internally into the stomach lumen.
Discuss signs and symptoms, treatment of CBD stone. Refer SRB
Note: SRB's Manual of Surgery is not available in this library. This answer follows the same structure and style as SRB, drawing from Sabiston, Bailey & Love, Schwartz, and Mulholland & Greenfield - all of which SRB references extensively.
| Type | Description |
|---|---|
| Secondary (most common) | Cholesterol or pigmented stones that form in the gallbladder and migrate into the CBD |
| Primary | Brown pigment stones forming de novo in the CBD; associated with bacterial infection (biliary stasis + Escherichia coli/Klebsiella); more common in Asian populations |
| Retained stones | Secondary stones found in CBD within 2 years of cholecystectomy (incidence 1-2%) |
| Recurrent stones | Found >2 years after cholecystectomy |
Fever + Jaundice + Right upper quadrant pain
Charcot's Triad + Hypotension + Altered mental status
| Test | Finding | Significance |
|---|---|---|
| Serum bilirubin | Elevated (conjugated/direct dominant) | Obstructive jaundice; >4 mg/dL = very high risk for CBD stone |
| ALP (Alkaline Phosphatase) | Markedly elevated | Best marker of biliary obstruction |
| GGT | Elevated | Confirms biliary origin |
| AST / ALT | Mildly elevated | Hepatocellular damage from back-pressure |
| PT/INR | Prolonged | Vitamin K malabsorption (fat-soluble vitamin) |
| WBC | Leukocytosis | Suggests cholangitis |
| Serum amylase/lipase | Elevated | Suggests gallstone pancreatitis |
| Urine | Bilirubin +ve, urobilinogen absent | Obstructive pattern |
| Modality | Findings | Notes |
|---|---|---|
| USG abdomen | Dilated CBD (>6 mm normal, >8 mm in elderly/post-cholecystectomy); stone may be seen with acoustic shadow | First-line; sensitivity ~80%, specificity ~90%; poor for distal CBD stones (gas shadow) |
| MRCP | "Filling defect" in dilated CBD; convex intraluminal shadow | Best non-invasive test; sensitivity >90%, specificity >99%; preferred when ERCP not immediately planned |
| ERCP | Direct visualisation of stone as filling defect; also therapeutic | Gold standard - diagnostic AND therapeutic in same sitting; complication rate ~10% |
| CT abdomen | Dilated CBD; stone (hyperdense); rules out other causes | Sensitivity ~90%; good for anatomy; not routine |
| EUS (Endoscopic USG) | Highly sensitive for small stones and distal CBD | Used when MRCP inconclusive; can guide ERCP |
| PTC (Percutaneous transhepatic cholangiogram) | Used when ERCP fails or altered anatomy | Also therapeutic |
| Intraoperative cholangiogram (IOC) | Confirms CBD clearance at time of cholecystectomy | Detects unsuspected stones in 1-2% |

| Risk Category | Predictors | Action |
|---|---|---|
| Very High | CBD stone on USG, OR cholangitis, OR bilirubin >4 mg/dL | Proceed directly to ERCP |
| High | Dilated CBD (>6mm) + bilirubin 1.8-4 mg/dL | EUS or MRCP, then ERCP |
| Low | Normal LFTs, no dilation, no stone | Cholecystectomy alone; no pre-op ERCP |
| Moderate | Any other abnormal LFT, age >55, gallstone pancreatitis | MRCP or EUS first |
T-tube placed in CBD after exploration
↓
Short limb in CBD lumen
Long limb exits through abdominal wall
↓
Postop Day 4-5: T-tube cholangiogram
(confirms duct clearance before capping tube)
↓
Retained stone found on cholangiogram?
→ Percutaneous extraction via T-tube tract (after 6 weeks)
↓
All clear: T-tube removed at 2-4 weeks
| Severity | Management |
|---|---|
| Mild | IV antibiotics alone (E. coli, Klebsiella coverage - e.g. piperacillin-tazobactam) |
| Moderate | Early biliary drainage (ERCP preferred) + IV antibiotics |
| Severe (Reynolds Pentad) | ICU, aggressive resuscitation → emergency biliary decompression (ERCP / PTC) → definitive treatment deferred until stable |
CBD Stone Suspected
↓
USG: Dilated CBD / stone seen?
↓
Risk Stratify (ASGE)
↓ ↓ ↓
High Risk Moderate Low Risk
ERCP first MRCP/EUS Lap Chole
↓ + IOC
CBD stone? → ERCP
↓
Stone cleared?
YES → Lap Chole (same admission)
NO → Open CBDE / T-tube / Biliary bypass
| Point | Fact |
|---|---|
| Stone in CBD = jaundice character | Painful, fluctuating (vs malignant = painless, progressive) |
| Charcot's Triad | Fever + Jaundice + RUQ pain = cholangitis |
| Reynolds' Pentad | Charcot's Triad + Hypotension + Altered sensorium = suppurative cholangitis |
| Courvoisier's Law | Palpable GB + painless jaundice = NOT stone (malignancy) |
| First-line treatment | ERCP + sphincterotomy + stone extraction |
| Surgical treatment | LCBDE (laparoscopic) or open choledochotomy ± T-tube |
| T-tube cholangiogram timing | Day 4-5 post-op; removed at 2-4 weeks if clear |
| Organisms in cholangitis | E. coli, Klebsiella, Enterobacter |
| Best non-invasive imaging | MRCP (sensitivity >90%, specificity >99%) |
| Best diagnostic + therapeutic | ERCP |
Obstructive Jaundice Final Year MBBS. SURGERY exam
| Type | Mechanism | Example |
|---|---|---|
| Pre-hepatic | Excess bilirubin production | Haemolysis |
| Hepatic (intrahepatic) | Hepatocyte damage/dysfunction | Hepatitis, cirrhosis |
| Post-hepatic (Obstructive) | Mechanical block to bile flow | Gallstone, carcinoma |
Surgery deals primarily with post-hepatic (obstructive) jaundice
Bile cannot enter duodenum
↓
Conjugated bilirubin regurgitates into blood
↓
Bilirubinaemia (conjugated/direct type)
↓
Filtered by kidney → Bilirubinuria (dark urine - "Coca-Cola urine")
↓
No bile pigments reach gut → Pale/clay-coloured stools
No urobilinogen in urine
↓
Bile salts accumulate in blood → Pruritus (bile salt skin deposits)
Bradycardia (bile salt vagal effect)
↓
Absence of bile in gut → Malabsorption of fat-soluble vitamins (A, D, E, K)
↓
Vitamin K deficiency → Impaired clotting (↑PT/INR) → Bleeding tendency
↓
Prolonged obstruction → Hepatocellular damage → Secondary biliary cirrhosis
| Sign | Significance |
|---|---|
| Icterus (yellow sclera) | Bilirubin >2-3 mg/dL |
| Scratch marks on skin | Pruritus from bile salts |
| Palpable, non-tender gallbladder | Courvoisier's sign - malignant obstruction |
| Hepatomegaly (smooth, tender) | Back-pressure from obstruction |
| Splenomegaly | Secondary biliary cirrhosis / portal hypertension |
| Charcot's Triad | Cholangitis (fever + RUQ pain + jaundice) |
| Reynolds' Pentad | Charcot's triad + hypotension + altered mental status = septic/suppurative cholangitis |
| Bradycardia | Bile salts (vagal effect) |
| Prolonged bleeding time | Vitamin K deficiency |
"If the gallbladder is palpably enlarged in the presence of jaundice, the jaundice is unlikely to be due to a stone"
| Test | Finding in Obstructive Jaundice |
|---|---|
| Serum Bilirubin | Elevated - conjugated (direct) fraction >50% |
| Alkaline Phosphatase (ALP) | Markedly elevated (3-4x normal) - best marker of cholestasis |
| GGT (Gamma-GT) | Elevated - confirms hepatobiliary origin (not bone) |
| AST / ALT | Mildly elevated (unlike viral hepatitis where these are very high) |
| Prothrombin Time (PT/INR) | Prolonged (Vit K deficiency); responds to IV Vitamin K = obstructive; no response = hepatocellular |
| Serum Albumin | Low in prolonged obstruction or malignancy |
| CA 19-9 | Tumour marker for pancreatic cancer |
| CEA | Elevated in GI malignancies |
| Urine | Bilirubin +ve; urobilinogen absent (complete obstruction) |
| Stool | Pale, clay-coloured; no stercobilinogen |
Key LFT Pattern in Obstructive Jaundice: High bilirubin (conjugated) + Markedly high ALP + Mildly raised AST/ALT
| Modality | Findings | Notes |
|---|---|---|
| USG Abdomen | Dilated biliary tree (CBD >6mm); gallstones; gallbladder size; pancreatic head mass | First-line investigation |
| CECT Abdomen | Level and cause of obstruction; vascular invasion; lymph nodes; liver metastases | Best for malignant causes; staging |
| MRCP | Non-invasive cholangiogram; shows entire biliary and pancreatic duct anatomy; filling defects | Best non-invasive test; sensitivity 95% |
| ERCP | Direct visualisation of biliary tree; also therapeutic (stenting, sphincterotomy, stone removal) | Gold standard; used when intervention planned |
| PTC (Percutaneous Transhepatic Cholangiogram) | Percutaneous access to biliary tree via liver; used when ERCP fails or hilar tumours | Also therapeutic - internal/external drainage |
| EUS | Evaluates distal CBD, ampulla, pancreatic head; FNA for tissue diagnosis | Useful when MRCP inconclusive |
| Liver Biopsy | Rules out hepatic causes | Rarely needed |
USG (first-line: dilated ducts? cause visible?)
↓
CECT (staging, vascular anatomy, resectability)
↓
MRCP (non-invasive biliary mapping)
↓
ERCP (if therapeutic intervention needed)
or PTC (if hilar block / ERCP failed)
| Problem | Preparation |
|---|---|
| Coagulopathy (Vit K deficiency) | Vitamin K1 10-20mg IV/IM daily; check PT before surgery; FFP if no response |
| Renal impairment (risk of hepatorenal syndrome) | IV fluids (keep well hydrated); mannitol 50g/day (osmotic diuretic); avoid nephrotoxic drugs |
| Cholangitis | IV antibiotics (piperacillin-tazobactam / cefoperazone-sulbactam); biliary drainage urgently |
| Malnutrition | Nutritional support - enteral preferred |
| Anaemia | Correct with blood transfusion pre-op |
Surgery in jaundiced patients carries ~20% mortality - proper pre-op preparation is essential
| Complication | Mechanism |
|---|---|
| Ascending cholangitis | Bacteria colonise obstructed biliary system |
| Hepatorenal syndrome | Bile salt + endotoxin renal tubular damage |
| Coagulopathy / Bleeding | Vitamin K malabsorption → ↓ clotting factors II, VII, IX, X |
| Secondary biliary cirrhosis | Prolonged back-pressure → hepatocyte damage |
| Septicaemia / septic shock | Untreated cholangitis |
| Malnutrition | Fat and fat-soluble vitamin malabsorption |
| Acute pancreatitis | Impacted stone at ampulla |
| Feature | CBD Stone | Carcinoma (Ca Pancreas) |
|---|---|---|
| Pain | Present (biliary colic) | Absent (painless jaundice) |
| Onset of jaundice | Sudden, fluctuating | Gradual, progressive, deepening |
| Fever | Often present (cholangitis) | Usually absent (unless late) |
| Gallbladder | Not palpable (fibrosed) | Palpably enlarged, non-tender (Courvoisier's sign) |
| Weight loss | Absent | Present (cachexia) |
| Stool | Pale (intermittently) | Persistently pale |
| ALP | Elevated | Very markedly elevated |
| USG | CBD stone, dilated CBD | Pancreatic head mass, dilated CBD + PD |
| CA 19-9 | Normal | Elevated |
| Treatment | ERCP + cholecystectomy | Whipple's / palliative stenting |
OBSTRUCTIVE JAUNDICE
↓
Conjugated bilirubin ↑ | ALP ↑↑↑ | GGT ↑ | AST/ALT mildly ↑
Dark urine | Pale stools | Pruritus | Coagulopathy
↓
Causes: Stones (painful, fluctuating) vs Malignancy (painless, progressive)
↓
Courvoisier's sign = palpable GB = malignancy
Charcot's triad = fever+jaundice+pain = cholangitis
Reynolds' pentad = Charcot's + shock + altered GCS = suppurative cholangitis
↓
Ix: USG → CECT → MRCP → ERCP/PTC
↓
Rx: Preop prep (Vit K, IV fluids, antibiotics)
Stones → ERCP + Lap Chole
Ca Pancreas resectable → Whipple's
Ca Pancreas unresectable → Stenting / Bypass